The St. Baldrick’s Foundation, a non-profit organization dedicated to raising money for childhood cancer research, awarded a grant of $100,000 to Jonathan Jaques Children's Cancer Center (JJCCC) at Miller Children's Hospital.
With this funding, JJCCC will actively participate in the Therapeutic Advances in Childhood Leukemia (TACL), a consortium that carries out early studies of new drugs in children with recurrent leukemia. The funding will support a clinical research nurse to launch the TACL program, which will allow JJCCC to work closely with other institutions to rapidly develop, execute and collect data to support expanded clinical trials proposed to the Children’s Oncology Group.
In addition, JJCCC envisions using this grant money to reactivate their participation in a national brain tumor endeavor, performing clinical studies with Phase I evaluations and participate in the Headstart Program that is based at Children’s Hospital of Los Angeles.